13/07/2026 - Campus Can Ruti, Research

A pilot clinical trial led by Germans Trias provides the first clinical proof of concept for ibuprofen as an adjunctive treatment for tuberculosis

The study, published in Nature Communications, evaluates ibuprofen for the first time in patients with tuberculosis as an adjunctive therapy aimed at modulating the host inflammatory response. The results did not show an improvement in the main clinical or microbiological outcomes, but they did reveal biological changes consistent with reduced inflammation, supporting further investigation of this approach in larger, controlled trials.

09/07/2026 - Campus Can Ruti, Projects, Research

BST and IGTP are advancing the use of the particles that cells use to communicate as revolutionary therapies for the future

Researchers from BST, IGTP and Biosfer Teslab have demonstrated the potential of Nuclear Magnetic Resonance to monitor and optimise the manufacture of extracellular vesicles, one of the most promising therapeutic platforms in regenerative medicine. The findings, published in the Journal of Extracellular Vesicles, could help facilitate the development and scale-up of these therapies.

01/07/2026 - Campus Can Ruti, Institutional, Success Stories

19 IGTP researchers, recognised in a scientific impact ranking

A total of 19 women researchers affiliated with the Germans Trias i Pujol Research Institute (IGTP) feature in the April 2026 edition of the Ranking of Spanish Women Researchers and Women Researchers in Spain, reflectig the relevance of the research conducted both at the institute and across the Can Ruti Campus.

18/06/2026 - Campus Can Ruti, Conferences, Innovation, Success Stories

The Innomed Awards support emerging biomedical projects with potential for transfer in health

The 3^rd Innomed Awards brought together professionals from research, healthcare, entrepreneurship and investment, with the presentation of the 15 projects taking part in the new edition of GrowInn and recognition for the seven projects with the greatest potential.

16/06/2026 - Campus Can Ruti, Projects

IGTP coordinates a new European COST Action on neurofibromatosis and schwannomatosis

IGTP will coordinate INTERACT-NF, a new European COST Action that will bring together 68 researchers from 13 countries to advance research on neurofibromatosis and schwannomatosis. The network will foster collaboration between researchers, clinicians and patient organisations to address the main challenges associated with these rare diseases.

15/06/2026 - Campus Can Ruti, Projects, Research

WHO launches an international study on the Andes hantavirus outbreak coordinated by professionals from the Germans Trias Hospital

Roger Paredes (Germans Trias Hospital, IrsiCaixa and the Fight Infections Foundation) coordinates the international NAVIS study, launched by the WHO to advance knowledge of Andes hantavirus. The initiative also includes an advanced virology and immunology study coordinated by IrsiCaixa and IGTP Principal Investigators Julià Blanco and Nuria Izquierdo-Useros.

12/06/2026 - Campus Can Ruti, Outreach, Success Stories

La Marató visits return to the IGTP laboratories to bring science closer to the public

IGTP has concluded a new cycle of visits to its laboratories as a part of La Marató "Visita la Recerca" program. More than fifty people had the opportunity to explore the biomedical research carried out at the institute through talks, workshops, and guided tours of the laboratories and facilities.

03/06/2026 - Campus Can Ruti, Innovation, Projects

AI-based voice assistant shows good usability for remote monitoring of patients affected by the digital divide

A team from the IGTP, in collaboration with the Home Hospitalisation Service (HAD) of the Germans Trias i Pujol University Hospital and the technology company Doole Health, has evaluated the usability of an artificial intelligence-based voice assistant for the remote clinical monitoring of patients. The results show good acceptance among both healthcare professionals and patients, including individuals with limited access to or use of digital technologies.

15/05/2026 - Campus Can Ruti, Institutional, Success Stories

IGTP launches the PATH program to strengthen advanced therapies at the Can Ruti Campus

IGTP has presented the PATH Advanced Therapies Program (Program of Advanced Therapies) at an event held on 14 May in the auditorium of Hospital Germans Trias i Pujol.

06/05/2026 - Campus Can Ruti, Projects, Research

CEEISCAT advances Pan-Téstate to strengthen online screening for HIV and viral hepatitis among GBMSM and trans women in Spain

CEEISCAT, a research group at IGTP, is developing Pan-Téstate, an online self-sampling program aimed at improving early screening for HIV and viral hepatitis among GBMSM and trans women in Spain. Using dried blood spot samples collected at home, the initiative seeks to reduce barriers to testing and improve access to early diagnosis and prevention.